1. Manemann SM, Bielinski SJ, Moser ED, St Sauver JL, Takahashi PY, Roger VL, et al. Variability in lipid levels and risk for cardiovascular disease: an electronic health record-based population cohort study. J Am Heart Assoc. 2023; 12:e027639.
Article
2. Lee S, Zhou J, Wong WT, Liu T, Wu WKK, Wong ICK, et al. Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning. BMC Endocr Disord. 2021; 21:94.
Article
3. Li S, Hou L, Zhu S, Yi Q, Liu W, Zhao Y, et al. Lipid variability and risk of cardiovascular diseases and all-cause mortality: a systematic review and meta-analysis of cohort studies. Nutrients. 2022; 14:2450.
Article
4. Wan EYF, Yu EYT, Chin WY, Barrett JK, Mok AHY, Lau CST, et al. Greater variability in lipid measurements associated with cardiovascular disease and mortality: a 10-year diabetes cohort study. Diabetes Obes Metab. 2020; 22:1777–88.
Article
5. Rhee M, Lee J, Lee ET, Yoon KH, Lee SH. Lipid variability induces endothelial dysfunction by increasing inflammation and oxidative stress. Endocrinol Metab. 2024; 39:511–20.
Article
6. Gahmberg CG, Tolvanen M, Kotovuori P. Leukocyte adhesion: structure and function of human leukocyte beta2-integrins and their cellular ligands. Eur J Biochem. 1997; 245:215–32.
7. Qu K, Yan F, Qin X, Zhang K, He W, Dong M, et al. Mitochondrial dysfunction in vascular endothelial cells and its role in atherosclerosis. Front Physiol. 2022; 13:1084604.
Article